The fate of [14C]disodium cromoglycate in man
- 1 July 1972
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 24 (7) , 525-531
- https://doi.org/10.1111/j.2042-7158.1972.tb09051.x
Abstract
The fate of [14C]disodium cromoglycate (DSCG) has been examined in 12 asthmatic patients. Maximum plasma concentrations (mean 9.2 ng/ml) were obtained within 15 min of inhaling DSCG (20 mg) and the average plasma half-life was 81 min. Although absorption from the lung is rapid, most of the inhaled dose is swallowed. Only 2.0% of the dose was excreted in the urine, and 84% was recovered from the faeces. DSCG is poorly absorbed from the gastrointestinal tract, only 0.4 % of an oral dose (20 mg) appeared in the 24 h urine and 83 % was recovered from the faeces. Intravenous administration of DSCG resulted in approximately equal amounts (30–50% of dose) being excreted via the urine and faeces. No metabolites of DSCG were detected chromatographically.Keywords
This publication has 6 references indexed in Scilit:
- The absorption, excretion and metabolism of disodium (14C)cromoglycate in manBiochemical Journal, 1971
- Administration of disodium cromoglycate.BMJ, 1969
- INHIBITORY EFFECTS OF DISODIUM CROMOGLYCATE ON ALLERGEN-INHALATION TESTSThe Lancet, 1968
- Dust removal from the lung parenchyma: an investigation of clearance stimulantsToxicology and Applied Pharmacology, 1968
- Biliary excretion in foreign compounds. Sulphonamide drugs in the ratBiochemical Journal, 1967
- A DOUBLE-BLIND TRIAL OF DISODIUM CROMOGLYCATE IN THE TREATMENT OF ALLERGIC BRONCHIAL ASTHMAThe Lancet, 1967